Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and related services for the global life sciences industry, today announced that its president and CEO, Richard T. Schumacher, was featured on the Uptick Newswire Stock Day Podcast with Everett Jolly. During the interview, Schumacher discussed the company’s recently-announced collaboration with NutraFuels Inc., the commercial launch of its BioPharmaceuticals contract services business and the publication of over 20 scientific papers on PBIO’s unique pressure-based products throughout 2018.
“We are a time-tested company with patents, products, a tremendous customer base, an expanding market, and increasing sales,” Schumacher stated in the interview. “We have struggled a bit over the past few years for a number of different reasons, but we believe we are past that now and on the road to success. Our three pressure-based technology platforms have been vetted by key opinion leaders globally, we have a number of leading scientists in the world who are using our various products, and we expect increased revenue in 2019 from our two new platform technologies (Barofold and UST). We believe that PBIO shareholders have much to be excited about going forward.”
To listen to the full interview, visit http://ibn.fm/WdJBQ
To view the full press release, visit http://ibn.fm/DU3fN
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment